Sign Up to like & get
recommendations!
0
Published in 2020 at "Cancer letters"
DOI: 10.1016/j.canlet.2020.06.002
Abstract: The master regulator of neuroendocrine differentiation, achaete-scute complex homolog 1 (ASCL1) defines a subgroup of lung adenocarcinoma. However, the mechanistic role of ASCL1 in lung tumorigenesis and its relation to the immune microenvironment is principally…
read more here.
Keywords:
lung adenocarcinoma;
ascl1;
ascl1 positive;
cell ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2017 at "Mechanisms of Development"
DOI: 10.1016/j.mod.2017.04.350
Abstract: During development, cortical interneurons generated from the ventral telencephalon migrate tangentially into the dorsal telencephalon. AlthoughAchaete-scute family bHLH transcription factor 1 (Ascl1) plays important roles in the developing telencephalon, whether Ascl1 regulates tangential migration remains…
read more here.
Keywords:
tangential migration;
outer membrane;
ascl1;
dorsal telencephalon ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2018 at "Cell Death and Differentiation"
DOI: 10.1038/s41418-018-0248-7
Abstract: Achaete-scute homolog 1 gene (ASCL1) is a gene classifier for the proneural (PN) transcriptional subgroup of glioblastoma (GBM) that has a relevant role in the neuronal-like differentiation of GBM cancer stem cells (CSCs) through the…
read more here.
Keywords:
gene ascl1;
expression;
ascl1;
transcriptional subgroup ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Cancer Science"
DOI: 10.1111/cas.15481
Abstract: Small cell lung cancer (SCLC) is a highly aggressive neuroendocrine tumor with dismal prognosis. Recently, molecular subtypes of SCLC have been defined by the expression status of ASCL1, NEUROD1, YAP1, and POU2F3 transcription regulators. ASCL1…
read more here.
Keywords:
molecular subtypes;
associated mirnas;
small cell;
ascl1 ... See more keywords
Sign Up to like & get
recommendations!
3
Published in 2023 at "Cancer Research"
DOI: 10.1158/1538-7445.am2023-4730
Abstract: Introduction: Second-generation AR pathway inhibitors such as Enzalutamide (ENZ) are highly effective in treating castration-resistant prostate cancer (CRPC). However, they play an important role in the emergence of AR-independent phenotypes, including treatment-induced neuroendocrine prostate cancer…
read more here.
Keywords:
cell;
prostate cancer;
ascl1;
chromatin ... See more keywords
Sign Up to like & get
recommendations!
2
Published in 2023 at "Cancer Research"
DOI: 10.1158/1538-7445.prca2023-pr004
Abstract: Most patients with prostate adenocarcinoma (PAd), an androgen receptor (AR) driven cancer, develop resistance to therapies targeting AR. Consequently, a portion of these patients develop neuroendocrine prostate cancer (NEPC), a rapidly progressing cancer with limited…
read more here.
Keywords:
prostate cancer;
small cell;
ascl1;
histology ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2018 at "Wellcome Open Research"
DOI: 10.12688/wellcomeopenres.14842.1
Abstract: The proneural basic-helix-loop-helix (bHLH) transcription factor Ascl1 is a master regulator of neurogenesis in both central and peripheral nervous systems in vivo, and is a central driver of neuronal reprogramming in vitro. Over the last…
read more here.
Keywords:
xenopus;
activity mouse;
ascl1;
protein ... See more keywords